Reckitt Benckiser Group (OTCMKTS:RBGLY) Upgraded at HSBC

HSBC upgraded shares of Reckitt Benckiser Group (OTCMKTS:RBGLYFree Report) from a hold rating to a buy rating in a research report released on Wednesday morning, Marketbeat reports.

A number of other research firms have also issued reports on RBGLY. JPMorgan Chase & Co. lowered shares of Reckitt Benckiser Group from an “overweight” rating to a “neutral” rating in a research note on Thursday, August 29th. Barclays raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a research note on Friday, October 4th. UBS Group raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a research note on Wednesday, September 18th. Citigroup raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a research note on Tuesday, October 1st. Finally, Sanford C. Bernstein lowered shares of Reckitt Benckiser Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 4th. Three analysts have rated the stock with a hold rating, one has given a buy rating and four have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Buy”.

Read Our Latest Report on Reckitt Benckiser Group

Reckitt Benckiser Group Trading Up 0.2 %

Shares of OTCMKTS:RBGLY opened at $12.26 on Wednesday. The company has a quick ratio of 0.47, a current ratio of 0.69 and a debt-to-equity ratio of 0.97. Reckitt Benckiser Group has a fifty-two week low of $10.24 and a fifty-two week high of $15.03. The firm has a 50-day simple moving average of $12.33 and a 200 day simple moving average of $11.73.

About Reckitt Benckiser Group

(Get Free Report)

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Read More

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.